We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Patient characteristics and reasons for discontinuation in a cardiovascular risk management programme in The Netherlands

    Background

    Since 2010, an increasing number of patients have participated in a nurse-led integrated cardiovascular risk management programme in the...

    Geert H.J.M. Smits, Sander van Doorn, ... Monika Hollander in BMC Primary Care
    Article Open access 11 February 2024
  2. Comparing the reasons for contraceptive discontinuation between parenting adolescents and young women in sub-Saharan Africa: a multilevel analysis

    Background

    Adolescent sexual and reproductive health remains a major public health and development issue of global importance. Given that adolescents...

    Sunday A. Adedini, Olusola A. Omisakin in Reproductive Health
    Article Open access 08 August 2023
  3. Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020

    Multiple myeloma (MM) is an incurable hematological cancer requiring multiple lines of anti-myeloma regimens to promote disease remission and...

    Marina Xavier Teixeira, Adriano Max Moreira Reis, ... Cristiane Aparecida Menezes de Pádua in Annals of Hematology
    Article 09 March 2024
  4. Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia

    Introduction

    This study assessed the levels of compliance to topical minoxidil (TM) among male and female patients with androgenetic alopecia (AGA)...

    Zari Shadi in Dermatology and Therapy
    Article Open access 03 April 2023
  5. Reasons for discontinuation of methotrexate in the treatment of rheumatoid arthritis and challenges of methotrexate resumption: a single-center, retrospective study

    Background

    Methotrexate (MTX) is an anchor drug used for the treatment of rheumatoid arthritis (RA); hence, understanding the reasons for MTX...

    Hiroko Nagafuchi, Yutaka Goto, ... Kimito Kawahata in Egyptian Rheumatology and Rehabilitation
    Article Open access 08 December 2022
  6. Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry

    Introduction

    The study aimed to optimize medical care for elderly patients with rheumatoid arthritis (RA) by examining the 3-year continuation rate...

    Satoshi Kubo, Yusuke Miyazaki, ... Yoshiya Tanaka in Rheumatology and Therapy
    Article Open access 19 October 2023
  7. General characteristics and reasons for the discontinuation of drug clinical trials in mainland China

    Background

    Although discontinuation is common in clinical trials, no study has been conducted to analyse the current situation and reasons for the...

    Ben-nian Huo, Mao-lin Ai, ... Lin Song in BMC Medical Research Methodology
    Article Open access 13 November 2021
  8. Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart review

    Administrative claims provide a rich data source for retrospective studies of real-world clinical practice, yet some important data may be...

    Adam Cuker, Lincy Lal, ... Ricardo Viana in Annals of Hematology
    Article 18 July 2022
  9. Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis

    Although tumor necrosis factor inhibitors (TNFi) have favorably altered the treatment landscape for patients with axial spondyloarthritis (axSpA),...

    Delamo I. Bekele, Elizabeth Cheng, ... Gail S. Kerr in Rheumatology International
    Article 01 November 2021
  10. Long–Term Outcome After Discontinuation of CGRP-Targeting Therapy for Migraine

    Purpose of review

    Calcitonin gene-related peptide (CGRP)-targeting agents are potential candidates for disease-modifying migraine drugs. However, most...

    Soohyun Cho, Byung–Kun Kim in Current Pain and Headache Reports
    Article 29 April 2024
  11. Exploring the Reasons Behind the Substantial Discontinuation Rate Among Patients Taking CT-P13 in a Large Tertiary Hospital in Western Switzerland: A Retrospective Cohort Study Using Routinely Collected Medical Data

    Background

    CT-P13 is an infliximab biosimilar that was granted market authorization in Switzerland in 2016. Despite the growing literature supporting...

    Marko Krstic, Jean-Christophe Devaud, ... Farshid Sadeghipour in Drugs - Real World Outcomes
    Article Open access 19 May 2022
  12. Predictors of contraceptive discontinuation in Rwanda: evidence from demographic and health survey 2019–2020

    Background

    Despite advancements, Rwanda continues to face challenges regarding contraceptive discontinuation. The 2019–2020 Rwanda Demographic and...

    Harerimana Jean de Dieu, Mugabo Lambert in Contraception and Reproductive Medicine
    Article Open access 25 April 2024
  13. Lithium-discontinuation-induced treatment refractoriness revisited

    Background

    Lithium is effective in the long-term treatment of bipolar disorder. Concerns have been raised about non-responsiveness after...

    Ralph Kupka, Eline Regeer, ... Michael Bauer in International Journal of Bipolar Disorders
    Article Open access 15 May 2024
  14. Postoperative use and early discontinuation of intravenous lidocaine in spine patients

    Purpose

    Our institution employs a multimodal approach to manage postoperative pain after spine surgery. It involves continuous intravenous (IV)...

    Paul Brian O. Soriano, Jason J. Haselhuhn, ... David W. Polly Jr. in Spine Deformity
    Article 23 August 2023
  15. Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media

    Introduction

    Hypertension is the leading cause of heart disease in the world, and discontinuation or nonadherence of antihypertensive medication...

    Cristina Micale, Su Golder, ... Graciela Gonzalez-Hernandez in Drug Safety
    Article 23 November 2023
  16. Peritoneal dialysis discontinuation: to the root of the problem

    As the global burden of chronic kidney disease continues to increase, the use of peritoneal dialysis is often advocated as the preferred initial...

    Paola Piarulli, Valerio Vizzardi, ... Antonio Bellasi in Journal of Nephrology
    Article Open access 25 September 2023
  17. Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial

    Background

    Antidepressants are established as an evidence-based, guideline-recommended treatment for Major Depressive Disorder. Prescriptions have...

    Carina Meißner, Claire Warren, ... Yvonne Nestoriuc in BMC Psychiatry
    Article Open access 21 June 2023
  18. Factors associated with discontinuation in fertility treatment: a systematic sco** review

    Purpose

    The discontinuation of fertility treatment could decrease the chances of achieving parenthood for infertile patients and often leads to...

    Quan Shen, Binglu Wang, ... Jun Lei in Journal of Assisted Reproduction and Genetics
    Article 21 November 2023
  19. Discontinuation of psychotropic medication: a synthesis of evidence across medication classes

    Pharmacotherapy is an effective treatment modality across psychiatric disorders. Nevertheless, many patients discontinue their medication at some...

    Christiaan H. Vinkers, Ralph W. Kupka, ... Jurjen J. Luykx in Molecular Psychiatry
    Article Open access 19 March 2024
  20. Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]

    Background

    Antidepressant discontinuation is associated with a broad range of adverse effects. Debilitating discontinuation symptoms can impede the...

    Amke Müller, Stefan Konigorski, ... Yvonne Nestoriuc in BMC Psychiatry
    Article Open access 13 October 2023
Did you find what you were looking for? Share feedback.